Meeting
2013 Gastrointestinal Cancers Symposium
Predictors of gastrointestinal toxicity during pelvic radiotherapy.
Authors
T. Jonathan Yang
Memorial Sloan-Kettering Cancer Center
T. Jonathan Yang , Jung Hun Oh , Christina Son , Aditya Apte , Joseph Deasy , Abraham Wu , Karyn Goodman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 31, 2013 (suppl 4; abstr472)
DOI
10.1200/jco.2013.31.4_suppl.472
Abstract #
472
Poster Bd #
C28
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Severe enterocolitis with capecitabine (CAPE) is not a predictor of gastrointestinal (GI) toxicity with infusional 5-fluorouracil (5-FU)–based regimens: An institutional analysis.
First Author: Marie Parish
Poster
2016 Gastrointestinal Cancers Symposium
Factors associated with acute toxicity during chemoradiation therapy for rectal cancer.
First Author: Pooja Monpara
Poster
2016 Genitourinary Cancers Symposium
Inflammatory bowel disease in patients with prostate cancer treated with radiation.
First Author: Matthew Maxwell Gestaut
Poster
2015 ASCO Annual Meeting
Phase I study of ganetespib (G), capecitabine (C), and radiation (RT) in rectal cancer.
First Author: Bassel F. El-Rayes